Skip to content

13F-HR filed by SPHERA FUNDS MANAGEMENT LTD.

SPHERA FUNDS MANAGEMENT LTD. filed this 13F-HR for the quarter ended 2015-09-30, filed 2015-11-16, with 127 holding rows worth $783,788,000.

Accession
0001178913-15-003433
Filed
2015-11-16
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2015

A holdings report, 128 entries on the cover page, a total value of $783,788,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $783,792,000 with VALUE read as thousands by filing date, 13F file number 028-15863. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
SELECT SECTOR SPDR TR81369Y959PUT10,000$66,230,000thousands by filing dateput
ALLERGAN PLCG0177J108SHS177,100$48,138,000thousands by filing date
SPDR S&P 500 ETF TR78462F953PUT2,451$46,969,000thousands by filing dateput
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS881624209ADR752,905$42,509,000thousands by filing date
SPDR SERIES TRUST78464A950PUT6,000$37,350,000thousands by filing dateput
ISHARES TR464287956ISHARES BIOTECH1,000$30,333,000thousands by filing dateput
ELBIT SYS LTD ORDM3760D101Stock100,618$29,169,000thousands by filing date
BIOGEN INC COM09062X103Stock85,000$24,804,000thousands by filing date
Pfizer Inc.717081103COM574,013$18,030,000thousands by filing date
AbbVie,Inc.00287Y109COM327,000$17,792,000thousands by filing date
ORMAT TECHNOLOGIES INC686688102COM132,659$17,551,000thousands by filing date
SHIRE PLC82481R106COMMON STOCK-FO169,751$13,252,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM125,000$13,165,000thousands by filing date
CELGENE CORP151020104COM120,000$12,980,000thousands by filing date
MYLAN N VN59465909CALL3,000$12,078,000thousands by filing datecall
Gilead Sciences,Inc.375558103COM120,000$11,783,000thousands by filing date
INCYTE CORP COM45337C102Stock100,000$11,033,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM105,000$9,656,000thousands by filing date
Bristol-Myers Squibb Company110122108COM150,000$8,880,000thousands by filing date
CELLCOM ISRAEL LTDM2196U109SHS357,452$8,793,000thousands by filing date
PERRIGO CO PLC SHSG97822103Stock547$8,603,000thousands by filing datecall
MYLAN NVN59465109SHS EURO200,000$8,052,000thousands by filing date
ACORDA THERAPEUTICS INC00484M106COM270,000$7,158,000thousands by filing date
Amgen Inc.031162100COM50,200$6,944,000thousands by filing date
HORIZON PHARMA PLCG4617B905CALL3,500$6,937,000thousands by filing datecall
DEPOMED INC249908104COM360,000$6,786,000thousands by filing date
SELECT SECTOR SPDR TR81369Y407SBI CONS DISCR89,216$6,625,000thousands by filing date
VANDA PHARMACEUTICALS INC921659108COM513,390$5,791,000thousands by filing date
CHECK POINT SOFTWARE TECH LTD ORDM22465104Stock72,327$5,738,000thousands by filing date
ALEXION PHARMACEUTICALS INC015351109COM35,000$5,474,000thousands by filing date
TESARO INC881569107COM117,500$4,712,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM310,000$4,337,000thousands by filing date
EGALET CORP28226B104COM325,000$4,284,000thousands by filing date
PTC THERAPEUTICS INC69366J900COM1,600$4,272,000thousands by filing datecall
INTRA-CELLULAR THERAPIES INC46116X101COMMON STOCK105,400$4,220,000thousands by filing date
Vertex Pharmaceuticals Incorporated92532F100COM40,000$4,166,000thousands by filing date
ALDER BIOPHARMACEUTICALS INC014339105COM125,000$4,095,000thousands by filing date
PORTOLA PHARMACEUTICALS INC COM737010108Stock95,000$4,049,000thousands by filing date
HORIZON PHARMA PLCG4617B105SHS200,000$3,964,000thousands by filing date
KEMPHARM INC COM NEW488445107Stock204,393$3,961,000thousands by filing date
GW PHARMACEUTICALS PLC36197T103ADS43,100$3,938,000thousands by filing date
UNITED THERAPEUTICS CORP DEL COM91307C102Stock28,840$3,785,000thousands by filing date
CONCERT PHARMACEUTICALS INC206022105COM200,000$3,754,000thousands by filing date
MACROGENICS INC556099109COM170,000$3,641,000thousands by filing date
Starbucks Corporation855244109COM62,683$3,563,000thousands by filing date
RAPTOR PHARMACEUTICAL CORP75382F106COM584,089$3,534,000thousands by filing date
ARRAY BIOPHARMA INC04269X905COM7,500$3,420,000thousands by filing datecall
AMAG PHARMACEUTICALS INC00163U106COM85,230$3,386,000thousands by filing date
BELLICUM PHARMACEUTICALS INC079481107COM231,514$3,364,000thousands by filing date
CATALYST PHARMACEUTICALS INC14888U101COM1,100,000$3,300,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock40,000$3,214,000thousands by filing date
FORWARD PHARMA A/S34986J105SPONSORED ADR135,000$3,181,000thousands by filing date
KITE PHARMA INC49803L109COM56,970$3,172,000thousands by filing date
CARA THERAPEUTICS INC140755109COM219,800$3,141,000thousands by filing date
ARROWHEAD RESEARCH CORP042797209COM540,000$3,110,000thousands by filing date
Arbutus Biopharma Corp03879J100Common Shares, without par value505,000$3,075,000thousands by filing date
INSMED INC COM PAR $.01457669307Stock165,000$3,064,000thousands by filing date
CYNAPSUS THERAPEUTICS INC23257Y859COM PAR NO PAR188,930$3,059,000thousands by filing date
RETROPHIN INC761299106COM150,000$3,039,000thousands by filing date
THERAPEUTICSMD INC88338N107COM512,500$3,003,000thousands by filing date
TJX Companies Inc872540109COM41,496$2,964,000thousands by filing date
ULTRAGENYX PHARMACEUTICAL IN90400D108COM30,700$2,957,000thousands by filing date
SPARK THERAPEUTICS INC84652J103COM70,000$2,921,000thousands by filing date
INTERCEPT PHARMACEUTICALS IN45845P108COM17,500$2,903,000thousands by filing date
VALEANT PHARMACEUTICALS INTL91911K102COM15,750$2,809,000thousands by filing date
EXELIXIS INC COM30161Q104Stock500,000$2,805,000thousands by filing date
FOAMIX PHARMACEUTICALS LTDM46135105SHS380,000$2,785,000thousands by filing date
Rocket Pharmaceuticals Inc45780V102SHS295,000$2,773,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM80,000$2,754,000thousands by filing date
ISIS PHARMACEUTICALS INC464330109COM68,000$2,749,000thousands by filing date
PALATIN TECHNOLOGIES INC696077403COM PAR $ .013,358,483$2,720,000thousands by filing date
FIVE PRIME THERAPEUTICS INC.33830X104Common Stock175,000$2,693,000thousands by filing date
NIVALIS THERAPEUTICS INC65481J109COM201,720$2,616,000thousands by filing date
CATABASIS PHARMACEUTICALS IN14875P107COM327,476$2,595,000thousands by filing date
GENOCEA BIOSCIENCES INC372427104COM377,200$2,584,000thousands by filing date
BIOTIE THERAPIES OYJ09074D103SPONSORED ADR196,800$2,576,000thousands by filing date
Mondelez International,Inc. Class A609207105COM59,475$2,490,000thousands by filing date
CYTOKINETICS INC23282W605COM NEW372,250$2,490,000thousands by filing date
ACCELERON PHARMA INC00434H108COM100,000$2,490,000thousands by filing date
KERYX BIOPHARMACEUTICALS492515101COMMON STOCK700,000$2,464,000thousands by filing date
DYNAVAX TECHNOLOGIES CORP268158201COM NEW100,000$2,454,000thousands by filing date
ABEONA THERAPEUTICS INC00289Y107COM600,000$2,430,000thousands by filing date
PARTNER COMMUNICATIONS CO LT70211M109ADR617,951$2,416,000thousands by filing date
UNIQURE NVN90064101SHS115,000$2,352,000thousands by filing date
ELLOMAY CAPITAL LIMITEDM39927120SHS221,097$2,335,000thousands by filing date
SCYNEXIS INC COM NEW811292101Common Stock313,000$2,279,000thousands by filing date
ATYR PHARMA INC002120103COM209,027$2,145,000thousands by filing date
SUMMIT THERAPEUTICS INC COM86627R102Stock205,200$2,136,000thousands by filing date
CEMPRA INC15130J109COM75,000$2,088,000thousands by filing date
IMMUNE DESIGN CORP.45252L103Common Stock170,000$2,074,000thousands by filing date
PROTHENA CORP PLC SHSG72800108Stock45,133$2,046,000thousands by filing date
AEGERION PHARMACEUTICALS INC00767E102COM150,000$2,040,000thousands by filing date
HALOZYME THERAPEUTICS INC COM40637H109Stock150,000$2,015,000thousands by filing date
WABTEC COM929740108Stock22,735$2,002,000thousands by filing date
RELYPSA INC759531106Common Stock107,000$1,981,000thousands by filing date
EPIZYME INC29428V104COM150,000$1,929,000thousands by filing date
SEATTLE GENETICS INC812578102COM50,000$1,928,000thousands by filing date
TRILLIUM THERAPEUTICS INC COM NEW89620X506Stock147,000$1,915,000thousands by filing date
NOVARTIS AG SPONSORED ADR66987V109ADR20,000$1,838,000thousands by filing date
SAREPTA THERAPEUTICS INC803607100COM55,000$1,766,000thousands by filing date
NEURODERM LTDM74231107ORD SHS85,000$1,757,000thousands by filing date
PALO ALTO NETWORKS INC697435105COM10,002$1,720,000thousands by filing date
NABRIVA THERAPEUTICS AG62957M104SPONSORED ADR175,000$1,663,000thousands by filing date
PIERIS PHARMACEUTICALS INC720795103COM900,000$1,647,000thousands by filing date
ZOGENIX INC.98978L204Common Stock120,000$1,620,000thousands by filing date
ARRAY BIOPHARMA INC COM04269X105Stock350,000$1,596,000thousands by filing date
OCERA THERAPEUTICS INC COM67552A108COM500,000$1,580,000thousands by filing date
ALDEYRA THERAPEUTICS INC01438T106COM265,000$1,545,000thousands by filing date
Carbylan Therapeutics Inc.141384107COM400,000$1,428,000thousands by filing date
MARINUS PHARMACEUTICALS INC56854Q101COM162,120$1,352,000thousands by filing date
TOBIRA THERAPEUTICS INC COM88883P101COM137,622$1,329,000thousands by filing date
ZAFGEN INC98885E103COM40,000$1,278,000thousands by filing date
COLUCID PHARMACEUTICALS INC19716T101COM317,250$1,228,000thousands by filing date
HERON THERAPEUTICS INC427746102COM50,000$1,220,000thousands by filing date
ORBOTECH LTDM75253100ORD78,482$1,213,000thousands by filing date
ANACOR PHARMACEUTICALS INC032420101COM10,000$1,177,000thousands by filing date
NOVAVAX INC670002104COMMON STOCK150,000$1,061,000thousands by filing date
AXALTA COATING SYS LTD COMG0750C108Stock40,626$1,029,000thousands by filing date
WIX COM LTD SHSM98068105Stock58,160$1,013,000thousands by filing date
GENVEC INC NEW37246C307cs360,325$832,000thousands by filing date
CHARTER COMMUNICATION - A16117M305COM4,026$708,000thousands by filing date
DELPHI AUTOMOTIVE PLCG27823106COMMON STOCK-FO9,150$696,000thousands by filing date
SMITH A O CORP COM831865209Stock10,441$681,000thousands by filing date
SAGE THERAPEUTICS INC78667J108COM8,000$339,000thousands by filing date
NICE LTD SPONSORED ADR653656108ADR4,525$255,000thousands by filing date
PTC THERAPEUTICS INC69366J200COM4,000$107,000thousands by filing date
AIMMUNE THERAPEUTICS INC.00900T107Common Stock200$5,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001178913-15-003433this filing2015-11-16acceptance time not in the bulk data set